‌

US Patent 11098289 Uricase sequences and methods of treatment

Patent 11098289 was granted and assigned to MedImmune, LLC on August, 2021 by the United States Patent and Trademark Office.

Is a

Patent Applicant

Current Assignee

Patent Jurisdiction

Patent Number

Patent Inventor Names

Manuel Baca0

Andrew C. Nyborg0

Date of Patent

August 24, 2021

Patent Application Number

201605130

Date Filed

May 13, 2016

Patent abstract

Described are improved uricase sequences having beneficial effects and methods of treating patients suffering from hyperuricemia.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 11098289 Uricase sequences and methods of treatment

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

By using this site, you agree to our Terms of Service.